Prevalence of Diabetic Retinopathy in the US in 2021

被引:68
|
作者
Lundeen, Elizabeth A. [1 ]
Burke-Conte, Zeb [2 ]
Rein, David B. [3 ]
Wittenborn, John S. [3 ]
Saaddine, Jinan [1 ]
Lee, Aaron Y. [4 ]
Flaxman, Abraham D. [2 ]
机构
[1] US Ctr Dis Control & Prevent, Div Diabet Translat, Vis Hlth Initiat, Atlanta, GA USA
[2] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA USA
[3] Univ Chicago, NORC, Chicago, IL USA
[4] Univ Washington, Dept Ophthalmol, Sch Med, Seattle, WA USA
关键词
GLYCEMIC CONTROL; UNITED-STATES; ETHNIC-DIFFERENCES; ADULTS; DISPARITIES; PROGNOSIS; MELLITUS; COHORT; HEALTH; TRENDS;
D O I
10.1001/jamaophthalmol.2023.2289
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Importance Diabetic retinopathy (DR) is a common microvascular complication of diabetes and a leading cause of blindness among working-age adults in the US.Objective To update estimates of DR and vision-threatening diabetic retinopathy (VTDR) prevalence by demographic factors and US county and state.Data Sources The study team included data from the National Health and Nutrition Examination Survey (2005 to 2008 and 2017 to March 2020), Medicare fee-for-service claims (2018), IBM MarketScan commercial insurance claims (2016), population-based studies of adult eye disease (2001 to 2016), 2 studies of diabetes in youth (2021 and 2023), and a previously published analysis of diabetes by county (2012). The study team used population estimates from the US Census Bureau.Study Selection The study team included relevant data from the US Centers for Disease Control and Prevention's Vision and Eye Health Surveillance System.Data Extraction and Synthesis Using bayesian meta-regression methods, the study team estimated the prevalence of DR and VTDR stratified by age, a nondifferentiated sex and gender measure, race, ethnicity, and US county and state.Main Outcomes and Measures The study team defined individuals with diabetes as those who had a hemoglobin A(1c) level at 6.5% or more, took insulin, or reported ever having been told by a physician or health care professional that they have diabetes. The study team defined DR as any retinopathy in the presence of diabetes, including nonproliferative retinopathy (mild, moderate, or severe), proliferative retinopathy, or macular edema. The study team defined VTDR as having, in the presence of diabetes, severe nonproliferative retinopathy, proliferative retinopathy, panretinal photocoagulation scars, or macular edema.Results This study used data from nationally representative and local population-based studies that represent the populations in which they were conducted. For 2021, the study team estimated 9.60 million people (95% uncertainty interval [UI], 7.90-11.55) living with DR, corresponding to a prevalence rate of 26.43% (95% UI, 21.95-31.60) among people with diabetes. The study team estimated 1.84 million people (95% UI, 1.41-2.40) living with VTDR, corresponding to a prevalence rate of 5.06% (95% UI, 3.90-6.57) among people with diabetes. Prevalence of DR and VTDR varied by demographic characteristics and geography.Conclusions and Relevance US prevalence of diabetes-related eye disease remains high. These updated estimates on the burden and geographic distribution of diabetes-related eye disease can be used to inform the allocation of public health resources and interventions to communities and populations at highest risk.
引用
收藏
页码:747 / 754
页数:8
相关论文
共 50 条
  • [1] Impact of Dyslipidemia Medications on the Prevalence of Diabetic Retinopathy Among a Large US Cohort
    Chadalavada, Srila
    Shaia, Jacqueline K.
    Russell, Matthew
    Talcott, Katherine
    Singh, Rishi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [2] Impact of Dyslipidemia Medications on the Prevalence of Diabetic Retinopathy Among a Large US Cohort
    Chadalavada, Srila H.
    Shaia, Jacqueline K.
    Russell, Matthew W.
    Talcott, Katherine E.
    Singh, Rishi P.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2023, 54 (11): : 626 - +
  • [3] PREVALENCE OF RETINOPATHY IN A DIABETIC CLINIC
    DONOVAN, RJ
    BRITISH MEDICAL JOURNAL, 1978, 1 (6125): : 1441 - 1442
  • [4] Prevalence of Diabetic Retinopathy in Greenland
    Lund-Andersen, H.
    Bybjerg, S.
    Valerius, M.
    Larsen, T. Jul
    Petersen, M. Lynge
    Juul, E.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (1_SUPPL) : 19 - 20
  • [5] PREVALENCE OF RETINOPATHY IN A DIABETIC POPULATION
    TEMESIO, P
    GALLEGO, L
    ANTES, JC
    FRASCHINI, JJ
    CASELLA, O
    REVISTA CLINICA ESPANOLA, 1977, 146 (06): : 363 - 366
  • [6] Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service
    Thomas, Rebecca L.
    Dunstan, Frank D.
    Luzio, Stephen D.
    Chowdhury, Sharmistha Roy
    North, Rachel V.
    Hale, Sarah L.
    Gibbins, Robert L.
    Owens, David R.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (01) : 64 - 68
  • [7] PUBERTY AND THE PREVALENCE OF DIABETIC-RETINOPATHY
    MURPHY, RP
    NANDA, M
    PLOTNICK, L
    AUER, C
    PATZ, A
    DIABETES, 1986, 35 : A211 - A211
  • [8] Prevalence of retinopathy in diabetic thalassaemic patients
    Incorvaia, C
    Parmeggiani, F
    Mingrone, G
    Sebastiani, A
    De Sanctis, V
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 1998, 11 : 879 - 883
  • [9] Rheumatoid arthritis and the prevalence of diabetic retinopathy
    Bartels, Christie M.
    Wong, Joanna C.
    Johnson, Sophia L.
    Thorpe, Carolyn T.
    Barney, Neal P.
    Sheibani, Nader
    Smith, Maureen A.
    RHEUMATOLOGY, 2015, 54 (08) : 1415 - 1419
  • [10] The prevalence of diabetic retinopathy in the United States
    Kempen, JH
    Friedman, DS
    Congdon, NG
    O'Colmain, BJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U1263 - U1263